Bioequivalence Study: Concepts, Approaches, Design, Various Regulatory Prospects  and Considerations

Akanksha; Roopam Tomar; Tanuja Singh; Shalini Sharma

doi:10.36948/ijfmr.2024.v06i03.23864

Bioequivalence Study: Concepts, Approaches, Design, Various Regulatory Prospects and Considerations

Author(s)	Akanksha, Roopam Tomar, Tanuja Singh, Shalini Sharma
Country	India
Abstract	The study of bioequivalence involves comparing various drug brands and their dosage forms. When the rate of dissolution and absorption of two different formulations of the same drug is identical, they are bioequivalent. Comparing the therapeutic effectiveness of two drugs that have the same active ingredient is necessary to assess the possibility of replacing an innovator with similar pharmaceuticals. Conducting a bioequivalence study involves conducting two methods: in-vitro and in-vivo. In-vivo bioequivalence study is usually carried out in human and animal subjects by measuring the rate and extent of drug absorption in the blood stream after a drug has been administered. Highly reliable information can be obtained from in-vivo studies. Furthermore, living organisms have a greater degree of variability. Conducting multiple trials is necessary, and the cost is also important. A dissolution apparatus is used for in-vitro bioequivalence studies. The necessary biological conditions are provided and samples are collected and analysed on a periodic basis. The system can be controlled by conducting in-vitro studies. It also allows for the imitation of biological conditions. By using in-vitro studies, the cost and number of trials can be decreased. The pharmaceutical industry and national regulatory authorities worldwide have embraced the concept of “BE”. Efforts are being made to understand and develop more effective and scientifically valid approaches to assess bioequivalence of various dosage forms. This article provides a brief review of the BE concepts, approaches, designs, and various basic regulatory considerations and prospects for conducting BE studies.
Keywords	Bioequivalence, Active Pharmaceutical Ingredient, In-vivo, In-vitro
Field	Medical / Pharmacy
Published In	Volume 6, Issue 3, May-June 2024
Published On	2024-06-30
Cite This	Bioequivalence Study: Concepts, Approaches, Design, Various Regulatory Prospects and Considerations - Akanksha, Roopam Tomar, Tanuja Singh, Shalini Sharma - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.23864
DOI	https://doi.org/10.36948/ijfmr.2024.v06i03.23864
Short DOI	https://doi.org/gt3nbx

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 4 Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9898-5948-55	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Bioequivalence Study: Concepts, Approaches, Design, Various Regulatory Prospects and Considerations

Share this